Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
http://www.citeulike.org/user/eisei/article/11753288
http://www.citeulike.org/user/eisei/article/11753288
No comments:
Post a Comment